Metraipolis › archive › dc_a535d7ab2fad

Targeting STAT5A via CRISPR/Cas9 restores TKI sensitivity in resistant chronic myeloid leukemia cells — Europe PMC PMID:42033509

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42033509
DOI
10.1007/s12032-[numero omesso]-6
License (as archived)
solo-consultazione
Archived
2026-11-03T05:35:43.434Z
SHA-256 of the archived text
d885259337f5d88e4167d83915ef24d8f449a1632c827e3f1b06a7d6359dd198
Stable URL of this page
https://metraipolis.com/documento/dc_a535d7ab2fad

How to cite

Targeting STAT5A via CRISPR/Cas9 restores TKI sensitivity in resistant chronic myeloid leukemia cells — Europe PMC PMID:42033509 — Europe PMC (en), https://europepmc.org/article/MED/42033509 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a535d7ab2fad (Metraipolis archive dc_a535d7ab2fad, sha256 d885259337f5d88e4167d83915ef24d8f449a1632c827e3f1b06a7d6359dd198)
BibTeX
@misc{dca535d7ab2fad,
  title = {Targeting STAT5A via CRISPR/Cas9 restores TKI sensitivity in resistant chronic myeloid leukemia cells — Europe PMC PMID:42033509},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42033509},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a535d7ab2fad; sha256 d885259337f5d88e4167d83915ef24d8f449a1632c827e3f1b06a7d6359dd198},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42033509. Agents can read the archived copy with the MCP tool read_document.